Letter to the Editor: Molecular Testing: Adoption and Disparities in Utilization Across the United States

Abstract

Get full access to this article

View all access options for this article.

References

Huang

, Chan

, Wright

, et al. Does the adoption of molecular testing cause decreased thyroidectomy rates in a national cohort? A Quasiexperimental Study of High- Versus Low-Adoption States. Thyroid, 2024; 34(3):388–398; doi: 10.1089/thy.2023.0651

Ospina

, Papaleontiou

. Thyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists. Endocr Pract, 2021; 27(3):261–268; doi: 10.1016/j.eprac.2021.02.003

Ochieng

, Clerveau

, Cubanski

, et al. A Snapshot of Sources of Coverage Among Medicare Beneficiaries. 2023. Available from: https://www.kff.org/medicare/issue-brief/a-snapshot-of-sources-of-coverage-among-medicare-beneficiaries/ [Last accessed: June 7, 2024 ].

Patel

, Yip

, Lubitz

, et al. The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg, 2020; 271(3):e21–e93; doi: 10.1097/SLA.0000000000003580

Ali

, Baloch

, Cochand-Priollet

, et al. The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid, 2023; 33(9):1039–1044; doi: 10.1089/thy.2023.0141